Is this you? Create Your Porfile
Avatar

Juliet Nabakka

Genomics Institute of the Novartis Research Foundation

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Juliet Nabakka is active.

Explore More

Publication

Featured researches published by Juliet Nabakka.

Journal of Medicinal Chemistry | 2007

N-Acylthiadiazolines, a New Class of Liver X Receptor Agonists with Selectivity for LXRβ

Valentina Molteni; Xiaolin Li; Juliet Nabakka; Fang Liang; John Wityak; Alan Koder; Leo Vargas; Russell Romeo; Nico Mitro; Puiying A. Mak; H. Martin Seidel; Jennifer Haslam; Donald Chow; Tove Tuntland; Tracy A. Spalding; Ansgar Brock; Michelle N. Bradley; Antonio Castrillo; and Peter Tontonoz; Enrique Saez

Bioorganic & Medicinal Chemistry Letters | 2004

Identification of novel potent bicyclic peptide deformylase inhibitors

Valentina Molteni; Xiaohui He; Juliet Nabakka; Kunyong Yang; Andreas Kreusch; Perry Gordon; Badry Bursulaya; Ian Warner; Tanya Shin; Tanya Biorac; Neil S. Ryder; Ronald L. Goldberg; J. R. Doughty; Yun He

Archive | 2007

Compositions and methods for modulating c-kit and pdgfr receptors

Donatella Chianelli; Christopher Cow; Yun He; Songchun Jiang; Xiaolin Li; Xiaodong Liu; Zuosheng Liu; Jon Loren; Valentina Molteni; Juliet Nabakka; Pingda Ren; Taebo Sim; Xiaodong Wang; Shuli You

Archive | 2008

2-heteroarylamino-pyrimidine derivatives as kinase inhibitors

Donatella Chianelli; Valentina Molteni; Xiaolin Li; Xiaodong Liu; Juliet Nabakka; Jon Loren

Archive | 2005

Compounds and compositions as lxr modulators

Valentina Molteni; Xiaolin Li; Juliet Nabakka; David Archer Ellis; Beth Anaclerio; Enrique Saez; John Wityak

Archive | 2009

HETEROCYCLIC COMPOUNDS AND COMPOSITIONS AS C-KIT AND PDGFR KINASE INHIBITORS

Xiaolin Li; Xiaodong Liu; Jon Loren; Valentina Molteni; Juliet Nabakka; Vince Yeh; Donatella Chianelli

Archive | 2012

Compounds and compositions as c-kit kinase inhibitors

Valentina Molteni; Hank Michael James Petrassi; Xiaolin Li; Xiaodong Liu; Jon Loren; Juliet Nabakka; Bao Nguyen; Vince Yeh

Archive | 2008

5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors

Valentina Molteni; Xiaolin Li; Xiaodong Liu; Donatella Chianelli; Juliet Nabakka; Jon Loren; Shuli You

Archive | 2004

Bicyclic compounds and compositions as pdf inhibitors

Valentina Molteni; Xiaohui He; Yun He; Andreas Kreusch; Juliet Nabakka; Kunyong Yang

Archive | 2017

composto como inibidor de c-kit cinase, seu uso, composição farmacêutica, e medicamento para o tratamento de uma doença mediada por uma cinase

Bao Nguyen; Hank Michael James Petrassi; Jon Loren; Juliet Nabakka; Valentina Molteni; Vince Yeh; Xiaodong Liu; Xiaolin Li

Explore More

Collaboration

Dive into the Juliet Nabakka's collaboration.

Top Co-Authors
Avatar

Valentina Molteni

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors
Avatar

Xiaolin Li

Novartis

View shared research outputs
Top Co-Authors
Avatar

Jon Loren

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors
Avatar

Xiaodong Liu

Novartis

View shared research outputs
Top Co-Authors
Avatar

Donatella Chianelli

Novartis

View shared research outputs
Top Co-Authors
Avatar

Vince Yeh

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors
Avatar

Bao Nguyen

Novartis

View shared research outputs
Top Co-Authors
Avatar

Yun He

Chongqing University

View shared research outputs
Top Co-Authors
Avatar

Andreas Kreusch

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors
Avatar

Enrique Saez

Scripps Research Institute

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge